Cargando…
Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease
Despite maximal medical therapy, a subset of patients with chronic obstructive pulmonary disease continue to suffer acute exacerbations. It is also clear that a subset of this population has elevated blood eosinophils. In addition to clearly responding better to inhaled corticosteroids, it is also p...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689550/ https://www.ncbi.nlm.nih.gov/pubmed/31496677 http://dx.doi.org/10.2147/COPD.S162781 |